Key result
Inhaled levosimendan improved hemodynamics and cardiac function in a postpartum patient with heart failure, providing symptomatic relief without the need for other inotropes.
Why the study?
Systemic levosimendan causes an excessive fall in SVR that often requires vasoconstrictors, whereas the inhalational route may exploit cardiac benefits with minimal effect on SVR.
Does inhaled levosimendan improve hemodynamics and cardiac function in a patient with peripartum cardiomyopathy?
Comparison
Inhaled levosimendan
Design
Case report
Authors
Loading...
May allow levosimendan use without vasoconstrictors in select cases; leaves open efficacy and safety in controlled trials.
Case Report (n=1)
No
Does inhaled levosimendan improve hemodynamics and cardiac function in a patient with peripartum cardiomyopathy?
Inhaled levosimendan may be a viable option to improve hemodynamics and symptoms in peripartum cardiomyopathy while avoiding the excessive fall in systemic vascular resistance seen with systemic administration.
Kaur et al. (2022) conducted a case report in Peripartum cardiomyopathy (n=1). Inhaled levosimendan was evaluated on Hemodynamic and clinical improvement. Inhaled levosimendan improved hemodynamics and cardiac function in a postpartum patient with heart failure, providing symptomatic relief without the need for other inotropes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: